Ranbaxy Laboratories Limited (NSE/BSE: Ranbaxy/500359) ("Ranbaxy") and Daiichi Sankyo Company Limited (TSE: 4568.JP) ("Daiichi Sankyo") today announced that t he Committee of the Board of Directors of ...

When Sun Pharma acquired troubled Ranbaxy in 2014 for $4 billion, the India generics giant knew it was inheriting some major compliance problems. At the time, four of Ranbaxy’s five plants were ...

Ranbaxy, a subsidiary of Ranbaxy Laboratories Ltd., India's biggest drugmaker, is operating under increased scrutiny from the U.S. Food and Drug Administration because of quality lapses at multiple ...

Ranbaxy's bid for summary judgment denied by U.S. district judge Ranbaxy delayed generics with false applications to regulators, say buyers (Reuters) - Sun Pharmaceutical Industries Ltd has lost a bid ...

Biz Around the StaeIndian generic drug maker Ranbaxy Laboratories Ltd., which has its U.S. offices in Plainsboro, said last week it has agreed to produce specific documents sought by the U.S.

June 11, 2008 - Ranbaxy Laboratories Limited (NSE/BSE: Ranbaxy/500359) ("Ranbaxy"), among the top 10 generic companies in the world and India's largest pharmaceutical company, and Daiichi Sankyo ...

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has revoked a tentative approval for Ranbaxy Laboratories Ltd to make a cheap copy of AstraZeneca Plc's heartburn drug Nexium, after its ...

Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd. (RLL, NSE: RANBAXY, BSE: 500359) ("Ranbaxy"), today announced that it has received final approval from the U.S.

(Reuters) - The New York Attorney General and the U.S. units of Ranbaxy Laboratories Ltd and Teva Pharmaceutical Industries Ltd have settled claims that an agreement between the two drugmakers ...

WASHINGTON/MUMBAI (Reuters) - Ranbaxy Laboratories Ltd (RANB.NS) has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure pill ...

The U.S. Food and Drug Administration (FDA) has revoked a tentative approval for India's Ranbaxy Laboratories to make a cheap copy of AstraZeneca's heartburn drug Nexium, after its Indian plants were ...

TRENTON, N.J. — Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some might contain tiny glass particles, the latest in a string of ...